IGI Laboratories Inc.


Company Update (NYSE:IG): IGI Laboratories, Inc. Announces Submission of Eighth ANDAs to the FDA

IGI Laboratories, Inc. (NYSEMKT:IG), a New Jersey based specialty generic pharmaceutical company, announced it has submitted its eighth abbreviated new drug applications (ANDAs) to …

Healthcare Insider Selling: Gilead Sciences, Inc. (GILD), bluebird bio Inc (BLUE), IGI Laboratories, Inc. (IG)

Recently, various executives in the healthcare industry have taken part in insider selling activity for the stocks of Gilead Sciences, Inc. (NASDAQ:GILD), bluebird bio Inc (NASDAQ:BLUE), …

Stock Update (NYSE:IG): IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015

IGI Laboratories, Inc. (NYSEMKT:IG), a New Jersey based specialty generic pharmaceutical company, today announced it has submitted its seventh abbreviated new drug application (ANDA) …

Here’s Why Roth Capital Slashed Price Target for IGI Laboratories, Inc.

Roth Capital’s healthcare analyst Scott Henry weighed in on IGI Laboratories, Inc. (NYSE:IG), maintainig a Neutral rating and reducing the price target to $7.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts